Exactech News (NASDAQ:EXAC)

DateTimeSource
Headline
04/25/20174:04PMBWExactech Q1 Revenue Up 6% to $69.5 Million on 21% Extremities Growth
Q1 Net Income $4.6 Million; Diluted EPS $0.32 Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that revenue for the first quarter of 2017 increased 6% to $69.5 million from $65.3 million in the first quarter... More...>>
04/12/201710:15AMBWExactech Schedules First Quarter 2017 Earnings Release and Conference Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, hip and knee will release its first quarter 2017 financial results on Tuesday, April 25, 2017. A copy of the earnings release will be available at http://www.hawkassociates.com. The company... More...>>
03/14/20178:55AMBWExactech Announces Full Launch of Three Revision Systems & Expansion of Advanced Surgical Technologies at AAOS 2017 Annual Me...
Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today its lineup of products to be showcased at the company’s educational exhibit, Booth #1433, at the American Academy of Orthopedic Surgeons (AAOS) 2017 Annual Meeting... More...>>
03/13/20178:55AMBWExactech Announces Investor Presentation at 12th Annual CanaccordGenuity Musculoskeletal Conference
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, will update investors at the 12th Annual CanaccordGenuity Musculoskeletal Conference in San Diego on Tuesday, March 14, 2017. The presentation by Exactech CEO and President... More...>>
02/21/20177:29AMBWExactech 2016 Revenue Up 7% to $257.6 Million, Q4’16 Revenue Increased 6% to $66.2 Million
Extremities Revenues Reached $100.3 Million, up 16% vs. Prior Year Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that revenue for 2016 increased 7% to $257.6 million from $241.8 million in 2015. Domestic... More...>>
02/13/201711:03AMBWExactech Schedules Fourth Quarter and Year-End 2016 Earnings Release and Conference Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, hip and knee will release its fourth quarter and year-end 2016 financial results before the market opens on Tuesday, February 21, 2017. A copy of the earnings release will be available... More...>>
01/31/20174:01PMBWExactech Announces Divestiture of Spine Assets and Restructuring Charges
With the goals of increasing productivity, enhancing profitability of its worldwide business, and strengthening its focus on core competencies, Exactech, Inc., (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, hip, knee and spine, has announced the restructuring of its Spine... More...>>
10/31/20164:04PMBWExactech Q3 Revenue Up 7% to $59.9 Million. Net Income up 10% to $3.2 Million. Diluted EPS $0.22 vs. $0.20.
Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, extremity, spine and biologic materials, today announced revenue of $59.9 million for the third quarter of 2016, a 7% increase from $56.2 million in the third quarter of 2015. On a constant currency basis, revenue... More...>>
10/24/20169:12AMBWExactech Schedules Third Quarter 2016 Earnings Release and Conference Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, hip, knee, and spine, will release its third quarter financial results after the market closes on Monday, October 31, 2016. A copy of the earnings release will be available at http://www.hawkassociates.com. The... More...>>
10/24/20169:05AMBWExactech Schedules Third Quarter 2016 Earnings Release and Conference Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, hip, knee, and spine, will release its third quarter financial results after the market closes on Monday, October 31, 2016. A copy of the earnings release will be available at http://www.hawkassociates.com. The... More...>>
10/13/20169:00AMBWExactech Breaks Ground in Foot and Ankle Market with Successful First Surgery
Product Expansion Capitalizes on Successful Extremities Business Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, hip, knee, and spine, announced today a successful first surgery using its new Vantage® Total Ankle System, the newest addition to the Exactech... More...>>
10/12/20161:40PMBWNew Studies Support Exactech’s Knee, Shoulder and Computer-Assisted Surgery Technologies
Exactech Innovations Presented at International Scientific Conference Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, today reported that studies involving its knee and shoulder joint replacement innovations and its ExactechGPS® guided personalized... More...>>
10/06/201612:18PMBWExactech Expands Its Computer-Assisted Surgery System With Revision Total Knee Replacement Application
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, today announced today the successful first U.S. surgery using the new application of ExactechGPS® Guided Personalized Surgery system for revision knee procedures. According to Exactech Chief... More...>>
09/29/20164:25PMBWExactech Announces Successful First Surgeries with New ExactechGPS® Total Shoulder Application
Expands proprietary ExactechGPS technology to the shoulder market for use with industry-leading Equinoxe® Shoulder System Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, today announced positive surgeon feedback on first surgeries performed... More...>>
09/06/20164:05PMBWExactech Announces Investor Presentation at Baird Global Healthcare Conference
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, will present to investors at the Baird 2016 Global Healthcare Conference in New York on Wednesday, September 7, 2016. The company will also host one-on-one meetings with institutional... More...>>
08/01/20164:05PMBWExactech Q2 Revenue Up 8% to $66.1 Million; Net Income up 20% to $4.4 Million; Diluted EPS $0.31 vs. $0.26
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced revenue of $66.1 million for the second quarter of 2016, an 8% increase from $61.5 million in the second quarter of 2015. On a constant currency basis, revenue... More...>>
07/14/20169:09AMBWExactech Schedules Second Quarter 2016 Earnings Release and Conference Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, will release its second quarter financial results after the market closes on Monday, August 1, 2016. A copy of the earnings release will be available at http://www.hawkassociates.com... More...>>
06/20/20169:00AMBWExactech Announces Full Launch of Acapella® One Cervical Spacer System
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, announced today the full launch of the new Acapella® One Cervical Spacer System. With the full launch of Acapella One, a cervical cage pre-assembled with integrated... More...>>
06/16/20169:00AMBWExactech Expands Competency in 3-D Printing with Purchase of Arcam Q10plus Systems
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, has confirmed the purchase of two Arcam Q10plus machines this week to expand its in-house manufacturing capabilities. This investment will advance Exactech’s long-term... More...>>
06/09/20164:59PMBWExactech & University of Florida Expand Partnership, Promote Health Education with Naming of “Exactech Arena” at the Step...
Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, announced today an expansion of its long-standing partnership with the University of Florida (UF) through naming of Exactech Arena at the newly remodeled Stephen C. O’Connell... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V:us D:20170428 17:53:54